- Home
- BRX vs RVMD Comparison
BRX vs RVMD Comparison
Compare BRX & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRX | RVMD |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.5B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BRX | RVMD |
|---|---|---|
| Price | $25.30 | $78.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 18 |
| Target Price | $30.08 | ★ $77.11 |
| AVG Volume (30 Days) | ★ 2.4M | 2.2M |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $1,346,289,000.00 | N/A |
| Revenue This Year | $7.62 | N/A |
| Revenue Next Year | $4.41 | $714.50 |
| P/E Ratio | $23.35 | ★ N/A |
| Revenue Growth | ★ 5.75 | N/A |
| 52 Week Low | $22.29 | $29.17 |
| 52 Week High | $29.99 | $81.49 |
Technical Indicators
Market Signals| Indicator | BRX | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 73.37 |
| Support Level | $24.66 | $77.31 |
| Resistance Level | $26.61 | $81.49 |
| Average True Range (ATR) | 0.40 | 2.57 |
| MACD | -0.06 | -0.26 |
| Stochastic Oscillator | 32.74 | 78.09 |
Price Performance
Historical ComparisonAbout BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.